Treatment of chronic urinary Salmonella carriers: 3-5 years follow-up.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002353:Carrier State / Q000188:drug therapy*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D009560:Niridazole / Q000627:therapeutic use; D012480:Salmonella Infections / Q000188:drug therapy*; D012482:Salmonella paratyphi A / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D000667:Ampicillin; D000965:Antimony; D009560:Niridazole